Ulta Beauty Stock Drops After Cautious 2026 Guidance Despite Strong Q4 Beat
Ulta Beauty beat holiday sales goals but gave lighter guidance for 2026 than Wall Street wanted, sending shares down 8% after hours.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Ulta Beauty beat holiday sales goals but gave lighter guidance for 2026 than Wall Street wanted, sending shares down 8% after hours.
Insulet has launched a voluntary medical device correction for specific lots of Omnipod 5 Pods due to possible tubing issues. All other pods remain safe.
Adobe smashed Q1 2026 records with $6.4B revenue and AI growth tripling, plus strong Q2 guidance. But CEO Shantanu Narayen is transitioning out, and shares fell 6% on AI competition fears.
Morgan Stanley and Cliffwater limit redemptions on major private credit funds after record withdrawal requests in Q1 2026, signaling investor concerns over liquidity and loan quality in the $1.8T market.
Hunterbrook report reveals Himax as stealth supplier of key optical components for Nvidia's AI data centers and possibly Apple's smart glasses. Stock jumps amid massive upside potential in CPO and AR tech.
Wolfpack Research released a critical short report questioning Babcock & Wilcox's $2.4 billion deal with Base Electron, a new RILY-backed company. APLD contradicts BW's claims and already has grid power agreements, casting major doubt on the project.